Imricor Medical Systems, Inc. (IMR.AX)
AUD 0.96
(-2.05%)
AUD 0.96
(-2.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 615.56 Thousand AUD | 13.65% |
| 2022 | 816.01 Thousand USD | 17.2% |
| 2021 | 696.26 Thousand AUD | -0.84% |
| 2020 | 702.16 Thousand AUD | 9.76% |
| 2019 | 639.7 Thousand AUD | -52.35% |
| 2018 | 1.34 Million AUD | 137.37% |
| 2017 | 565.59 Thousand AUD | -19.65% |
| 2016 | 703.91 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 203.87 Thousand USD | -2.11% |
| 2024 Q2 | 203.87 Thousand USD | 0.0% |
| 2023 Q1 | 99.5 Thousand USD | -28.43% |
| 2023 FY | 927.38 Thousand AUD | 13.65% |
| 2023 Q4 | 208.28 Thousand USD | 0.0% |
| 2023 Q3 | 208.28 Thousand USD | 109.32% |
| 2023 Q2 | 99.5 Thousand USD | 0.0% |
| 2022 FY | 816.01 Thousand USD | 17.2% |
| 2022 Q3 | 139.03 Thousand USD | -48.31% |
| 2022 Q2 | 268.97 Thousand USD | 0.0% |
| 2022 Q1 | 268.97 Thousand USD | 62.99% |
| 2022 Q4 | 139.03 Thousand USD | 0.0% |
| 2021 Q3 | 165.02 Thousand USD | -9.88% |
| 2021 Q4 | 165.02 Thousand USD | 0.0% |
| 2021 Q2 | 183.11 Thousand USD | -0.0% |
| 2021 FY | 696.26 Thousand AUD | -0.84% |
| 2021 Q1 | 183.11 Thousand USD | -13.76% |
| 2020 Q1 | 138.76 Thousand USD | -52.57% |
| 2020 Q3 | 212.31 Thousand USD | 53.0% |
| 2020 Q2 | 138.76 Thousand USD | 0.0% |
| 2020 Q4 | 212.31 Thousand USD | 0.0% |
| 2020 FY | 702.16 Thousand AUD | 9.76% |
| 2019 Q1 | 27.27 Thousand USD | -82.74% |
| 2019 FY | 639.7 Thousand AUD | -52.35% |
| 2019 Q4 | 292.58 Thousand USD | 0.0% |
| 2019 Q3 | 292.58 Thousand USD | 972.86% |
| 2019 Q2 | 27.27 Thousand USD | -0.0% |
| 2018 Q3 | 158 Thousand USD | -53.96% |
| 2018 Q1 | 343.22 Thousand USD | 0.0% |
| 2018 Q2 | 343.22 Thousand USD | 0.0% |
| 2018 Q4 | 158 Thousand USD | 0.0% |
| 2018 FY | 1.34 Million AUD | 137.37% |
| 2017 FY | 565.59 Thousand AUD | -19.65% |
| 2016 FY | 703.91 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 83.603% |
| Adherium Limited | 840.98 Thousand AUD | 26.804% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 99.028% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 84.937% |
| Anteris Technologies Ltd | 4.11 Million AUD | 85.027% |
| Control Bionics Limited | 5.12 Million AUD | 87.993% |
| CardieX Limited | 10.9 Million AUD | 94.356% |
| Compumedics Limited | 49.71 Million AUD | 98.762% |
| Cochlear Limited | 2.25 Billion AUD | 99.973% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 96.085% |
| Cyclopharm Limited | 27.13 Million AUD | 97.732% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 94.513% |
| Nova Eye Medical Limited | 23.32 Million AUD | 97.361% |
| HeraMED Limited | 402.89 Thousand AUD | -52.785% |
| ImpediMed Limited | 10.31 Million AUD | 94.035% |
| InhaleRx Limited | 1.2 Million AUD | 48.875% |
| LBT Innovations Limited | 1.25 Million AUD | 50.99% |
| Micro-X Limited | 15.22 Million AUD | 95.956% |
| Neurotech International Limited | 1963.00 AUD | -31258.533% |
| OncoSil Medical Limited | 1.56 Million AUD | 60.676% |
| PolyNovo Limited | 103.19 Million AUD | 99.403% |
| Respiri Limited | 456.91 Thousand AUD | -34.723% |
| SomnoMed Limited | 91.65 Million AUD | 99.328% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 90.719% |
| Uscom Limited | 3.72 Million AUD | 83.483% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 92.9% |